|
Enlil's Purpose-Built Development Traceability Platform Gains Momentum Across the Global MedTech Ecosystem
Wednesday, May 7, 2025
The all-in-one, cloud-native solution integrates AI-powered intelligence to transform how OEMs and contract manufacturers manage development, ensure compliance, and accelerate time-to-market.
CAMPBELL, Calif., April 29, 2025 /PRNewswire/ -- Enlil, Inc., a Shifamed portfolio company accelerating innovation for regulated products with its comprehensive development traceability platform, today announced growing momentum across the global MedTech innovation ecosystem. Since the February appointment of seasoned technology leader Nader Fathi as CEO, Enlil has significantly expanded its reach among OEMs, contract manufacturers, and industry partners. With over 600 users worldwide, Enlil is revolutionizing how the MedTech innovation ecosystem can streamline the path to commercialization through the digital acceleration of product development, compliance, and regulatory readiness.
At the core of Enlil's offering is its use of AI-powered intelligence, including a private large language model (LLM)-driven chatbot. By embedding secure, contextual AI into its platform, Enlil's chatbot Ask Lily extracts insights with unprecedented speed and accuracy, empowering engineering, quality, and regulatory teams to make smarter decisions without compromising sensitive IP or compliance integrity.
Purpose-built to overcome the challenges of fragmented technology stacks and siloed documentation, Enlil's platform enables end-to-end traceability, secure cross-functional collaboration, and regulatory agility from ideation to post-market surveillance. The platform integrates key product development disciplines--Requirements Management, QMS, PLM, Manufacturing, ERP, Regulatory Compliance, and Post-Market Surveillance--into a unified digital thread, allowing distributed teams to work together in real-time.
"Today's MedTech ecosystem demands more than legacy tools patched together--it needs a platform designed for regulatory complexity, distributed collaboration, and speed," said Nader Fathi, CEO of Enlil. "Enlil bridges the gap between iteration and regulation, empowering teams to bring breakthrough devices to market faster and more confidently."
Uniquely, Enlil's development traceability platform:
-- Leverages private AI to accelerate regulatory workflows: Features like
AI-driven insights and real-time change control help teams stay ahead of
compliance requirements, making the process less burdensome.
-- Supports complex development relationships: Facilitates seamless
collaboration across innovation hubs, contract manufacturers, and OEMs,
regardless of geography.
-- Manages diverse product types: Enlil supports MedTech hardware, Software
in a Medical Device (SiMD), Software as a Medical Device (SaMD),
diagnostics, high tech, and more.
Built with geographically diverse teams in mind, Enlil empowers OEMs and contract manufacturers to streamline documentation, enhance visibility, and reduce regulatory friction at every development milestone.
"MedTech companies increasingly understand that generic, retrofitted solutions from other industries are inadequate for their unique regulatory demands," added Fathi. "We engineered Enlil from the ground up to meet the complexity of MedTech compliance. That is why our platform is rapidly becoming the go-to system for organizations serious about accelerating safe, high-quality innovation."
Enlil is investing in talent and partnerships to meet growing demand as it expands its global presence. Backed by advanced AI capabilities and the strength of the Shifamed innovation network, Enlil is establishing itself as the leading platform for regulated product development.
About Enlil
Enlil, Inc., a Shifamed portfolio company, delivers a cloud-native development traceability platform that unifies compliance, quality, and engineering across the product development lifecycle. Purpose-built for regulated industries, Enlil empowers MedTech innovators with digital traceability, real-time collaboration, and AI-driven insights--accelerating time to market while maintaining rigorous regulatory standards. Visit enlil.com for more information.
About Shifamed
Shifamed is a Silicon Valley-based medical innovation hub founded by serial entrepreneur Amr Salahieh. Focused on accelerating time-to-market for life-changing health technologies, Shifamed supports its portfolio companies with deep technical expertise, operational excellence, and a proven path to successful commercialization. Learn more at shifamed.com.
MEDIA CONTACT
Sandra Schwartzman
RMR & Associates
(301) 230 - 0045 x 100
sschwartzman@rmr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/enlils-purpose-built-development-traceability-platform-gains-momentum-across-the-global-medtech-ecosystem-302440501.html
SOURCE Enlil, Inc.
|
|
|
|
|
|
 |
Energy Toolbase Launches Energy Storage Partnership with Sungrow to Support PowerStack 255CS and PowerTitan 2.0 | Jan 22, 2026
|
|
RS now offers Phoenix Contact's pioneering new NearFi technology | Jan 22, 2026
|
|
MetaOptics to Showcase Five Breakthrough Metalens-Powered Products at CES 2026 | Jan 22, 2026
|
|
Fresco Raises EUR15m Series C to Power the Future of AI-Driven Cooking and the Connected Kitchen Ecosystem | Jan 22, 2026
|
|
No Assembly Required: Barrett Distribution Centers Powers Maxwood Furniture's West Coast DTC Expansion | Jan 22, 2026
|
|
SCAILIUM Debuts "AI Production Layer" to Overcome GPU Starvation and Slash AI Energy Waste | Jan 22, 2026
|
|
Hesai Recognized as the Only Lidar Company on Morgan Stanley's "Humanoid Tech 25" of Global Robotics Leaders | Jan 22, 2026
|
|
Einride and IonQ Partnership Uses Quantum Computing to Optimize the Logistics of Electric and Autonomous Freight | Jan 22, 2026
|
|
Daikin Applied Invests $163M in Advanced R&D Test Lab to Bolster HVAC Innovation for Data Centers and Beyond | Jan 22, 2026
|
|
Lumana Surpasses 50,000 Cameras, Cementing Its Leadership in AI Video Surveillance | Jan 22, 2026
|
|
|
|
